CLPT

CLEARPOINT NEURO INC

CLPT·18507C103·US·Common Stock·Healthcare - Medical Devices-13D/G

CLPT (CLEARPOINT NEURO INC) is held by 64 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($19M), VANGUARD CAPITAL MANAGEMENT LLC ($11.3M), GEODE CAPITAL MANAGEMENT, LLC ($6.4M). Net institutional sentiment: Mixed.

64
Holders
Avg rating(19 Elite)
$80.8M
Total Value
63% (75)
Fund Consensus
43 buying - 25 selling
CLPTSmart Money Verdict
View all
Held by 64 funds
19 elite
Who's Trading
ActivistMAMAK Capital Fund LP6.3%May 15, 2026
ActivistBLBIGGER CAPITAL FUND L P4.5%Apr 20, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderBJBURNETT JOSEPHSell $303KFeb 25, 2026
InsiderBJBURNETT JOSEPHSell $46KJan 26, 2026
InsiderBJBURNETT JOSEPHSell $322KJan 9, 2026
InsiderBJBURNETT JOSEPHSell $466KOct 10, 2025
InsiderBJBURNETT JOSEPHSell $182KOct 10, 2025
InsiderBJBURNETT JOSEPHSell $57KOct 10, 2025
InsiderBJBURNETT JOSEPHSell $9KOct 10, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.1M(+1.9%)$19M0.0%+32.62%
29
New
1.2M$11.3M0.0%+97.96%
39
Increased
705,720(+7.8%)$6.4M0.0%+52.31%
29
Increased
679,819(+8.2%)$6.2M0.0%+30.74%
29
Increased
463,617(+59.7%)$4.2M0.0%+48.34%
38
Increased
432,360(+27.2%)$3.9M0.0%+12.98%
33
Decreased
325,906(-1.5%)$3M0.0%+45.09%
0
New
284,809$2.6M0.0%+97.96%
36
Decreased
231,974(-55.0%)$2.1M0.0%+23.44%
0
Increased
230,941(+1.2%)$2.1M0.0%-14.07%
26
Decreased
210,780(-3.9%)$1.9M0.0%-16.19%
0
Increased
209,426(+8.3%)$1.9M0.0%+60.30%
28
New
205,755$1.9M0.0%+97.96%
36
New
156,971$1.4M0.0%+97.96%
35
Increased
143,747(+39.5%)$1.3M0.0%+54.73%
34
Decreased
136,284(-9.5%)$1.2M0.0%+28.96%
0
Increased
129,872(+15.3%)$1.2M0.0%+58.83%
29
Unchanged
105,033$955,8000.0%+48.26%
0
Increased
83,170(+5.4%)$756,8470.0%+57.15%
26
Increased
71,448(+9.0%)$650,1800.0%+53.21%
27

Showing 1-20 of 75

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used